Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

1996-09-09

Original market date: See footnote 1

1989-12-31

Product name:

OPTREX PLUS DECONGESTANT EYE DROPS

DIN:

00751316 Electronic product monograph is not available

Company:

OPTREX LABS LTD.
City Wall Howse
Basingstoke
Saone Et Loire
United Kingdom R621 2JP

Class:

Human

Dosage form(s):

Drops

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

52:32.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

S01GA51 NAPHAZOLINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0219608001

List of active ingredient(s)
Active ingredient(s) Strength
HAMAMELIS VIRGINIANA 12.5 %
NAPHAZOLINE HYDROCHLORIDE 0.01 %
Version 4.0.2
Date modified: